1. Christopher Jon Olesch Jr. Christopher Jon Olesch Jr. United States says:

    Why waste our time & resources when most of these problems have already been solved by other countries.
    European regulatory authorities aim to minimise the impact of medicine shortages on patients by:

        working with pharmaceutical companies to resolve manufacturing and distribution issues;
        sharing information with international partners about alternative sources of supply;
        seeking input from patients and healthcare professionals on the impact of medicine shortages, to support decision-making;
        taking measures to allow alternative medicines or suppliers to be used.

    The Agency maintains a catalogue of shortages that it has assessed.
    www.ema.europa.eu/.../general_content_000588.jsp&mid=WC0b01ac05807477a5

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post